Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
Marcos Pasarín, Vincenzo La Mura, Jordi Gracia‐Sancho et al. · PLoS ONE · 2012
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Most morbidity associated with the metabolic syndrome is related to vascular complications, in which endothelial dysfunction is a major pathogenic factor. However, whether NAFLD is associated with endothelial dysfunction within the hepatic vasculature is unknown. The aims of this study were to explore, in a model of diet-induced overweight that expresses most features of the metabolic syndrome, whether early NAFLD is associated with liver endothelial dysfunction. Wistar Kyoto rats were fed a cafeteria diet (CafD; 65% of fat, mostly saturated) or a control diet (CD) for 1 month. CafD rats developed features of the metabolic syndrome (overweight, arterial hypertension, hypertryglyceridemia, hyperglucemia and insulin resistance) and liver steatosis without inflammation or fibrosis. CafD rats had a significantly higher in vivo hepatic vascular resistance than CD. In liver perfusion livers from CafD rats had an increased portal perfusion pressure and decreased endothelium-dependent vasodilation. This was associated with a decreased Akt-dependent eNOS phosphorylation and NOS activity. In summary, we demonstrate in a rat model of the metabolic syndrome that shows features of NAFLD, that liver endothelial dysfunction occurs before the development of fibrosis or inflammation.
Cited by 247 works. doi:10.1371/journal.pone.0032785 Open-access PDF
Authors
- Marcos Pasarín
- Vincenzo La Mura
- Jordi Gracia‐Sancho
- Héctor García‐Calderó
- Aina Rodrı́guez-Vilarrupla
- Juan Carlos García‐Pagán
- Jaime Bosch
- Juan G. Abraldeṣ
References
- Harmonizing the Metabolic Syndrome
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
- Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress
- Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels
- Atherosclerosis is an inflammatory disease
- Role of Endothelial Dysfunction in Atherosclerosis
- Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat
- Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
- Metabolic Syndrome
- Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration